Bill Text: CA AB2998 | 2023-2024 | Regular Session | Amended


Bill Title: Opioid overdose reversal medications: pupil administration.

Spectrum: Slight Partisan Bill (Democrat 6-2)

Status: (Engrossed) 2024-06-20 - Read second time and amended. Re-referred to Com. on APPR. [AB2998 Detail]

Download: California-2023-AB2998-Amended.html

Amended  IN  Senate  June 20, 2024
Amended  IN  Assembly  April 29, 2024
Amended  IN  Assembly  April 11, 2024
Amended  IN  Assembly  April 01, 2024

CALIFORNIA LEGISLATURE— 2023–2024 REGULAR SESSION

Assembly Bill
No. 2998


Introduced by Assembly Member McKinnor
(Coauthors: Assembly Members Alanis, Bonta, Haney, Jones-Sawyer, Ortega, Joe Patterson, and Schiavo)

February 16, 2024


An act to add Section 49414.35 to the Education Code, relating to pupil health.


LEGISLATIVE COUNSEL'S DIGEST


AB 2998, as amended, McKinnor. Opioid overdose reversal medications: pupil administration.
Existing law authorizes a public or private elementary or secondary school to determine whether or not to make emergency naloxone hydrochloride or another opioid antagonist and trained personnel available at its school, and to designate one or more volunteers to receive related training to address an opioid overdose, as specified. Existing law prohibits a person who has completed that training and who administers naloxone hydrochloride or another opioid antagonist, in good faith and not for compensation, to a person who appears to be experiencing an opioid overdose from being subject to professional review, liable in a civil action, or subject to criminal prosecution for the person’s acts or omissions in administering the naloxone hydrochloride or another opioid antagonist, unless the person’s acts or omissions constituted gross negligence or willful and wanton misconduct, as provided.
This bill would prohibit a school district, county office of education, or charter school from prohibiting a pupil 12 years of age or older, while on a schoolsite or participating in school activities, from carrying or administering, for the purposes of providing emergency treatment to persons who are suffering, or reasonably believed to be suffering, from an opioid overdose, specified opioid overdose reversal medications that are a naloxone hydrochloride nasal spray or any other opioid overdose reversal medication that is federally approved for over-the-counter, nonprescription use, as provided. The bill would prohibit a pupil 12 years of age or older of those local educational agencies who administers naloxone hydrochloride or another opioid antagonist those opioid antagonists on a schoolsite or while participating in school activities, in good faith and not for compensation, to a person who appears to be experiencing an opioid overdose, from being held liable in a civil action or being subject to criminal prosecution for their acts or omissions, unless the pupil’s acts or omissions constitute gross negligence or willful and wanton misconduct, as provided. The bill would also prohibit those local educational agencies, or an employee of those local educational agencies, from being subject to professional review, liable in a civil action, or subject to criminal prosecution for a pupil’s acts or omissions in administering naloxone hydrochloride or another opioid antagonist, those opioid antagonists, unless an act or omission of the local educational agency, or the employee of the local educational agency, constitutes gross negligence or willful and wanton misconduct connected to the administration of the naloxone hydrochloride or another opioid antagonist. those opioid antagonists.
Vote: MAJORITY   Appropriation: NO   Fiscal Committee: YES   Local Program: NO  

The people of the State of California do enact as follows:


SECTION 1.

 Section 49414.35 is added to the Education Code, immediately following Section 49414.3, to read:

49414.35.
 (a) Notwithstanding any other law or regulation, a local educational agency shall not prohibit a pupil 12 years of age or older, while on a schoolsite or participating in school activities, from carrying or administering, for the purposes of providing emergency treatment to persons who are suffering, or reasonably believed to be suffering, from an opioid overdose, either (1) a naloxone hydrochloride nasal spray that is federally approved for over-the-counter, nonprescription use or (2) any other opioid overdose reversal medication that is federally approved for over-the-counter, nonprescription use. or another opioid antagonist.
(b) Notwithstanding any other law or regulation, a pupil 12 years of age or older of a local educational agency who administers naloxone hydrochloride or another opioid antagonist on a schoolsite or while participating in school activities, in good faith and not for compensation, to a person who appears to be experiencing an opioid overdose shall not be liable in a civil action or be subject to criminal prosecution for their acts or omissions in administering the naloxone hydrochloride or another opioid antagonist, unless the pupil’s acts or omissions constitute gross negligence or willful and wanton misconduct connected to the administration of the naloxone hydrochloride or another opioid antagonist.
(c) Notwithstanding any other law or regulation, a local educational agency, or an employee of a local educational agency, shall not be subject to professional review, liable in a civil action, or subject to criminal prosecution for a pupil’s acts or omissions in administering naloxone hydrochloride or another opioid antagonist, unless an act or omission of the local educational agency, or the employee of the local educational agency, constitutes gross negligence or willful and wanton misconduct connected to the administration of the naloxone hydrochloride or another opioid antagonist.
(d) For purposes of this section, “local educational the following definitions apply:
(1) “Local educational agency” means a school district, county office of education, or charter school.
(2) “Naloxone hydrochloride or another opioid antagonist” means either of the following:
(A) A naloxone hydrochloride nasal spray that is federally approved for over-the-counter, nonprescription use.
(B) Any other opioid overdose reversal medication that is federally approved for over-the-counter, nonprescription use.

feedback